Show simple item record

FieldValueLanguage
dc.contributor.authorEugenie, Macfarlane
dc.date.accessioned2023-03-03T04:02:38Z
dc.date.available2023-03-03T04:02:38Z
dc.date.issued2023en_AU
dc.identifier.urihttps://hdl.handle.net/2123/30147
dc.descriptionIncludes publication
dc.description.abstractGlucocorticoids regulate numerous cellular processes in nearly all body systems, including skeletal homeostasis, inflammation, and circadian rhythms. Previous work from our group indicates that glucocorticoid signaling in bone cells promotes the development of murine osteoarthritis. However, whether glucocorticoid signaling in chondrocytes also affects osteoarthritis is unknown. Furthermore, studies suggest that chronic disruption of circadian rhythms contributes to osteoarthritis and poor skeletal health. While glucocorticoids are potent synchronisers of circadian rhythms throughout the body, the role of endogenous glucocorticoid signaling in mediating the effects of chronic disruption of circadian rhythms on joints and bones has not been investigated. To address these questions, two mouse lines were used in which the glucocorticoid receptor was selectively deleted in either chondrocytes or osteoblasts/osteocytes. These mice were examined in three disease settings: i) osteoarthritis, ii) bone loss induced by disruption of circadian rhythm and iii) osteoarthritis during circadian rhythm disruption. i.In murine osteoarthritis, deletion of the glucocorticoid receptor in chondrocytes attenuated synovial activation, chondrocyte senescence and cartilage loss. ii.Chronic disruption of circadian rhythm induced bone loss in wild-type mice. In contrast, osteoblast/osteocyte glucocorticoid receptor knockout mice were protected from this phenotype, displaying increased bone volume. iii.Chronic disruption of circadian rhythm accelerated osteoarthritic cartilage loss in wild-type and osteoblast/osteocyte glucocorticoid receptor knockout mice. Conversely, in mice with deletion of the chondrocyte glucocorticoid receptor, osteoarthritic cartilage loss was mitigated. These novel findings establish endogenous glucocorticoid signaling as a critical mediator of the deleterious effects of osteoarthritis and skeletal pathologies associated with chronic disruption of circadian rhythm.en_AU
dc.language.isoenen_AU
dc.subjectglucocorticoidsen_AU
dc.subjectosteoarthritisen_AU
dc.subjectbone lossen_AU
dc.subjectcircadian rhythm disruptionen_AU
dc.subjectglucocorticoid receptoren_AU
dc.subjectcartilageen_AU
dc.titleThe Role of Endogenous Glucocorticoids and Circadian Rhythm Disruption in Osteoarthritis and Bone Lossen_AU
dc.typeThesis
dc.type.thesisDoctor of Philosophyen_AU
dc.rights.otherThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en_AU
usyd.facultySeS faculties schools::Faculty of Medicine and Healthen_AU
usyd.departmentConcord Clinical Schoolen_AU
usyd.degreeDoctor of Philosophy Ph.D.en_AU
usyd.awardinginstThe University of Sydneyen_AU
usyd.advisorZHOU, HONG
usyd.include.pubYesen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.